These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1693662)

  • 21. Identification of monoclonal antibody epitopes and critical residues for rhinovirus binding in domain 1 of intercellular adhesion molecule 1.
    McClelland A; deBear J; Yost SC; Meyer AM; Marlor CW; Greve JM
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7993-7. PubMed ID: 1716769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance.
    Glaser AL; de Vries AA; Dubovi EJ
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2223-33. PubMed ID: 7561759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
    Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
    J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping of antigenic sites involved in neutralization on the capsid protein of feline calicivirus.
    Tohya Y; Yokoyama N; Maeda K; Kawaguchi Y; Mikami T
    J Gen Virol; 1997 Feb; 78 ( Pt 2)():303-5. PubMed ID: 9018050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.
    Xie QC; McCahon D; Crowther JR; Belsham GJ; McCullough KC
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1637-47. PubMed ID: 2438378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2.
    Francis MJ; Hastings GZ; Sangar DV; Clark RP; Syred A; Clarke BE; Rowlands DJ; Brown F
    J Gen Virol; 1987 Oct; 68 ( Pt 10)():2687-91. PubMed ID: 2822846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.
    Bolwell C; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():59-68. PubMed ID: 2471783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
    Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the newly identified neutralization epitopes on VP7 of human rotavirus serotype 1.
    Kobayashi N; Taniguchi K; Urasawa S
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():117-24. PubMed ID: 1703558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Location of the major antigenic sites involved in rotavirus serotype-specific neutralization.
    Dyall-Smith ML; Lazdins I; Tregear GW; Holmes IH
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3465-8. PubMed ID: 2422651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants.
    Crowther JR; Farias S; Carpenter WC; Samuel AR
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1547-53. PubMed ID: 8393912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody.
    Smith TJ; Olson NH; Cheng RH; Liu H; Chase ES; Lee WM; Leippe DM; Mosser AG; Rueckert RR; Baker TS
    J Virol; 1993 Mar; 67(3):1148-58. PubMed ID: 7679742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and construction of rhinovirus chimeras incorporating immunogens from polio, influenza, and human immunodeficiency viruses.
    Arnold GF; Resnick DA; Li Y; Zhang A; Smith AD; Geisler SC; Jacobo-Molina A; Lee W; Webster RG; Arnold E
    Virology; 1994 Feb; 198(2):703-8. PubMed ID: 7507283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and location of cross-reactive and serotype-specific neutralization sites on VP7 of human G type 9 rotaviruses.
    Kirkwood C; Masendycz PJ; Coulson BS
    Virology; 1993 Sep; 196(1):79-88. PubMed ID: 8395127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
    Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.
    Rockman S; Camuglia S; Vandenberg K; Ong C; Baker MA; Nation RL; Li J; Velkov T
    Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus.
    Balasuriya UB; Maclachlan NJ; De Vries AA; Rossitto PV; Rottier PJ
    Virology; 1995 Mar; 207(2):518-27. PubMed ID: 7533965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies to a peptide of human rhinovirus type 2 with different specificities recognize the same minimum sequence.
    Barnett PV; Rowlands DJ; Campbell RO; Parry NR
    J Gen Virol; 1995 May; 76 ( Pt 5)():1255-61. PubMed ID: 7730811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralization and infection-enhancement epitopes of influenza A virus hemagglutinin.
    Tamura M; Webster RG; Ennis FA
    J Immunol; 1993 Aug; 151(3):1731-8. PubMed ID: 7687637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.